ProServices presents Verona Pharma Plc. represented by the CEO of the company Mr. Jan-Anders Karlsson on July, 17th 2014, at 12h00 at “CERCLE MUNSTER” in Luxembourg.
Verona Pharma Plc. is an AIM listed biotech company with a core focus on developing novel therapeutics for respiratory diseases. The company has 2 products in clinical development. The most promising drug candidate RPL554 is a novel PDE3/4 inhibitor for the treatment of respiratory diseases, including asthma and COPD. The company is headed by a very experienced management and board.